ClearPoint Neuro, Inc. (CLPT) Gross margin 2017–2025
ClearPoint Neuro, Inc. (CLPT) gross margin by fiscal year — reported gross profit divided by reported revenue.
61.4%FY2025 · since FY2017: 60.7% → 61.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 61.4% | +0.5 pp |
| FY2024 | 60.9% | +4.1 pp |
| FY2023 | 56.8% | -9.0 pp |
| FY2022 | 65.8% | -2.4 pp |
| FY2021 | 68.2% | -2.8 pp |
| FY2020 | 71.1% | +6.2 pp |
| FY2019 | 64.9% | -2.1 pp |
| FY2018 | 66.9% | +6.2 pp |
| FY2017 | 60.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Net marginCLPT Gross profitCLPT Operating incomeCLPT Operating marginCLPT Operating cash flowCLPT Free cash flowCLPT Capital expendituresCLPT Return on equityCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Total liabilitiesCLPT Shareholders’ equityCLPT overview →